Dell BIOS Vulnerability Could Lead to Code Execution
CVE-2024-32858

8.2HIGH

Key Information:

Vendor

Dell
Status
Cpg BiOS
Vendor
CVE Published:
13 June 2024

What is CVE-2024-32858?

The Dell Client Platform BIOS contains an Improper Input Validation vulnerability which resides in an externally developed component. This vulnerability can be exploited by a high privileged local attacker, potentially leading to unauthorized code execution on the affected system. It is crucial for organizations to review the affected versions of the BIOS and apply the recommended remediation measures to mitigate the risk associated with this weakness. For detailed information, please refer to the vendor advisory.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

CPG BIOS < 2.8.0

CPG BIOS < 1.0.24

CPG BIOS < 1.1.25

References

https://www.dell.com/support/kbdoc/en-us/000223439/dsa-20...
vendor-advisory

CVSS V3.1

Score:
8.2
Severity:
HIGH
Confidentiality:
High
Integrity:
High
Availability:
High
Attack Vector:
Local
Attack Complexity:
Low
Privileges Required:
High
User Interaction:
None
Scope:
Changed

Timeline

  • Vulnerability published

  • Vulnerability Reserved

Credit

Dell Technologies would like to thank Eason for reporting this issue
JSON
.